Schedule of Disaggregated Revenue (Details) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Product Information [Line Items]
Total revenue, net	$ 8,519,047	$ 1,927,720	$ 17,087,965	$ 2,147,654
Core [Member]
Product Information [Line Items]
Total revenue, net			16,563,906	2,147,654
Noncore [Member]
Product Information [Line Items]
Total revenue, net			17,087,965	2,147,654
Sale of Pharmaceutical Products Rx Compound and Peaks [Member] | Core [Member]
Product Information [Line Items]
Total revenue, net			16,563,906	2,147,654
Shipping Income [Member] | Noncore [Member]
Product Information [Line Items]
Total revenue, net			$ 524,059